Clopidogrel Resistance

This publication has 29 references indexed in Scilit:

• ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary
  Circulation, 2004
• Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial Infarction
  Circulation, 2004
• Contribution of Hepatic Cytochrome P450 3A4 Metabolic Activity to the Phenomenon of Clopidogrel Resistance
  Circulation, 2004
• Clopidogrel for Coronary Stenting
  Circulation, 2003
• Impact of angina class on inhibition of platelet aggregation following clopidogrel loading in patients undergoing coronary intervention: Do we need more aggressive dosing regimens in unstable angina?
  Catheterization and Cardiovascular Interventions, 2003
• Atorvastatin Reduces the Ability of Clopidogrel to Inhibit Platelet Aggregation
  Circulation, 2003
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
  BMJ, 2002
• The P2Y 12 receptor as a therapeutic target in cardiovascular disease
  Platelets, 2001
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
  The Lancet, 1996
• Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary Angioplasty
  New England Journal of Medicine, 1988